PRESS RELEASE published on 07/05/2024 at 22:00, 1 year 7 months ago Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position Inventiva updates on its clinical program evaluating lanifibranor for MASH/NASH, with positive recruitment and financial outlook. New patents strengthen the company's position Financial Position Clinical Program Inventiva Lanifibranor MASH/NASH
BRIEF published on 06/21/2024 at 22:05, 1 year 7 months ago Results of the Combined Shareholders' General Meeting of June 20, 2024 Shareholders' Meeting Resolutions Votes Inventiva
PRESS RELEASE published on 06/21/2024 at 22:05, 1 year 7 months ago Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024 Description of the share repurchase program authorized by the Ordinary General Meeting of 20 June 2024 by Inventiva SA. Details on objectives, maximum capital proportion, and allocation of treasury shares presented Liquidity Agreement Ordinary General Meeting AMF General Regulations Share Repurchase Program Inventiva SA
PRESS RELEASE published on 06/21/2024 at 22:00, 1 year 7 months ago Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024 Inventiva announces voting results of Combined Shareholders' Meeting held on June 20, 2024. All resolutions, except 30th, were adopted. Details of votes and quorum provided Voting Results Quorum Combined Shareholders' Meeting Resolutions Adopted Inventiva
BRIEF published on 05/30/2024 at 08:35, 1 year 8 months ago Inventiva: Status of voting rights and shares as of May 13, 2024 Euronext Paris Share Capital Voting Rights Financial Transparency Inventive
BRIEF published on 05/30/2024 at 08:35, 1 year 8 months ago Inventiva Combined General Meeting of June 20, 2024 - Conditions for making preparatory documents available Shareholders Biopharmaceutical General Assembly Preparatory Documents Inventive
BRIEF published on 05/27/2024 at 09:12, 1 year 8 months ago Crossing threshold for INVENTIVA Capital Transfer Of Shares Crossing Threshold Inventiva UBS Group AG
BRIEF published on 05/21/2024 at 22:05, 1 year 8 months ago Inventiva Releases First Quarter 2024 Financial Results and Business Updates Financial Results Treasury BEI Inventive NATiV3 Clinical Trials
PRESS RELEASE published on 05/21/2024 at 22:00, 1 year 8 months ago Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options Financial Information Deposits Clinical Trial Cash Inventiva
Published on 02/07/2026 at 01:00, 1 day 5 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 7 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 8 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 15 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 17 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 9 hours 35 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 13 hours 59 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 14 hours 14 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 11 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 12 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 12 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 14 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 2 days 12 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026